The authors assessed the efficacy and safety of rosuvastatin monotherapy, extended-release (ER) niacin monotherapy, or rosuvastatin and ER niacin combined therapy in patients with atherogenic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback